This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Axon AI tool for US police reports shows need for transparency, EFF says

By Emma Whitford ( July 10, 2025, 21:38 GMT | Insight) -- An artificial intelligence tool by law enforcement equipment manufacturer Axon generates police reports without preserving a record of officer edits, making it difficult to trace errors and bias to the source and creating a liability quagmire, according to a report out today from the Electronic Frontier Foundation, a US civil liberties nonprofit. Pending legislation in California seeks to bring transparency to how AI-assisted police reports are drafted.An artificial intelligence tool by law enforcement equipment manufacturer Axon Enterprise, Inc. generates police reports without preserving a record of officer edits, making it difficult to trace errors and bias to the source and creating a liability quagmire, according to a report out today from the Electronic Frontier Foundation, a US civil liberties nonprofit....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections